Annexure-1 Patents Granted for Drugs (Products and Processes)

Annexure-1 Patents Granted for Drugs (Products and Processes)

ANNEXURE‐1‐ Patents Granted for Drugs/Medicines (Products and Processes) related to fields of Chemicals and Biotechnology during last 3 years and current year . Application_number Patent_date_Of_G TITLE_OF_INVENTION PATENT_NUMBER rant 1432/MUMNP/2010 01‐04‐2016 A METHOD OF ADAPTING THE PROCEDURE FOR EPICUTANEOUS 272455 DESENSITIZATION 1844/KOLNP/2008 01‐04‐2016 [4‐(6‐HALO‐7‐SUBSTITUTED ‐2,4‐DIOXO‐1,4‐DIHYDRO‐2H‐ 272457 QUINAZOLIN‐3‐YL)‐PHENYL]‐5‐CHLORO‐THIOPHEN‐2‐YL‐ SULFONYLUREAS AND FORMS AND METHODS RELATED THERETO 2284/CHE/2007 05‐04‐2016 STILBENE BASED COMPOUNDS AS HDAC INHIBITORS 272490 306/DELNP/2009 05‐04‐2016 "A COMPOSITION FOR ENHANCING EXECUTIVE COGNITIVE 272500 FUNCTION IN A HEALTHY HUMAN SUBJECT" 3512/KOLNP/2008 05‐04‐2016 BIFUNCTIONAL HISTONE DEACETYLASE INHIBITORS 272514 3451/DELNP/2006 07‐04‐2016 "VINFLUNINE PHARMACEUTICAL COMPOSITION AND PROCESS FOR 273980 PREPARING THE SAME." 2481/MUM/2008 10‐04‐2016 PREPARATION OF PHENYLACETIC ACID DERIVATIVE 276185 2019/MUM/2008 12‐04‐2016 STABLE ORAL ATORVASTATIN FORMULATION AND PROCESS OF ITS 272594 PREPARATION 4334/DELNP/2008 12‐04‐2016 “A LENTIVIRAL VECTOR‐BASED VACCINE” 272595 118/DELNP/2009 12‐04‐2016 “STABLE LAQUINIMOD PREPARATIONS” 272596 4129/KOLNP/2009 12‐04‐2016 RECONSTITUTED SURFACTANTS HAVING IMPROVED PROPERTIES 272602 2218/CHE/2007 13/04/2016 CARBON NANOSPHERE‐N‐(4‐CHLORO‐3‐TRIFLUOROMETHYL‐ 272637 PHENYL)‐2‐ETHOXY‐6‐PENTADECYLBENZAMIDE COMPOSITION AND A PROCESS THEREOF 1876/KOLNP/2010 13‐04‐2016 COMPOSITIONS AND METHODS FOR TREATING DISEASES OF THE 272623 NAIL 3140/CHENP/2006 13‐04‐2016 PHARMACEUTICAL COMPOSITIONS COMPRISING IBOPAMINE 272638 MALEATE AND PROCESS FOR PREPARING THE SAME 1106/MUM/2010 18‐04‐2016 CINAMIC COMPOUNDS AND DERIVATIVES THEREFROM FOR THE 272653 INHIBITION OF HISTONE DEACETYLASE 3893/KOLNP/2007 18‐04‐2016 A METHOD FOR PRODUCING AN EXTRACT OF GINKGO BILOBA 272655 HAVING A REDUCED CONTENT OF 4'‐O‐METHYL PYRIDOXINE AND BIFLAVONES 2754/DELNP/2009 18‐04‐2016 "A METHOD OF MAKING STANNSOPORFIN AND STANNSOPORFIN 272659 SO PRODUCED" 679/DELNP/2009 19‐04‐2016 "PHARMACEUTICAL COMPOSITIONS 457" 272674 266/MUM/2011 19‐04‐2016 LIPOPOLYMERIC NANOCAPSULES FOR DELIVERING HYDROPHOBIC 272675 DRUGS 131/MUM/2006 19‐04‐2016 NOVEL 11β‐HYDROXYANDROSTA‐4‐ENE‐3‐ONES 272676 52/MUMNP/2011 20‐04‐2016 “A NATURAL ALLICIN TABLET AND PREPARATION METHOD 272692 THEREOF” 478/DELNP/2011 22/04/2016 "THE USE OF WNT5‐A PEPTIDE DERIVATES FOR THE TREATMENT OF 272745 MELANOMA AND GASTRIC CANCER" 1352/MUM/2006 25‐04‐2016 ANTIMICROBIAL DERIVATIVES OF ANACARDIC ACID AND PROCESS 272748 FOR PREPARING THE SAME 358/MUMNP/2009 25‐04‐2016 “MODIFIED ERYTHROPOIETIN” 272749 2190/MUM/2011 26‐04‐2016 "A NANOCOCHLEATE ‐NANOSPHERE COMPLEX" 272767 212/MUM/2010 26‐04‐2016 COMPLEXED ANTIBODY‐SUBSTRATE NANO‐PARTICULATES FOR 272769 BINDING OF CHROMATIN FRAGMENTS 523/MUM/2007 26‐04‐2016 A METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION 272779 COMPRISING FLUCONAZOLE 146/MUM/2012 26‐04‐2016 TRANSNASAL MICROEMULSION OF AN ANTISPASTIC AGENT 272781 518/KOLNP/2009 27‐04‐2016 METHODS OF SYNTHESIS AND/OR PURIFICATION OF 272791 DIAMINOPHENOTHIAZINIUM COMPOUNDS 1664/KOLNP/2007 27‐04‐2016 AN OPHTHALMIC OIL‐IN‐WATER EMULSION 272797 1113/MUM/2008 27‐04‐2016 COMBINED MEASLES‐HUMAN PAPILLOMA VACCINE FOR 272803 THERAPEUTIC AND PROPHYLACTIC USE Page 1 of 85 4028/DELNP/2009 27‐04‐2016 “PROCESS FOR MANUFACTURING OPHTHALMIC OIL‐IN‐WATER 272807 EMULSIONS” 2078/MUM/2007 28/04/2016 STABLE PHARMACEUTICAL COMPOSITIONS OF CALCITRIOL AND 272821 MINERAL SUPPLEMENTS 2728/KOLNP/2007 28‐04‐2016 A PROCESS FOR THE PRODUCTION OF A TABLET 272820 212/DELNP/2011 03‐05‐2016 "MULTIPHASE PERSONAL CARE COMPOSITION WITH ENHANCED 272918 DEPOSITION" 8751/DELNP/2007 04‐05‐2016 "A HOMOGENEOUS PHARMACEUTICAL COMPOSITION FOR 272946 TREATING INFLAMMATORY DISORDER" 3849/CHENP/2008 06‐05‐2016 A READY TO DRINK LIQUID FOR ALZHEIMER PATIENTS 272979 1992/DEL/2008 06‐05‐2016 "1,2,4,5‐TETRAHYDRO‐3H‐BENZAZEPINE COMPOUNDS, A PROCESS 272987 FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM" 2271/KOLNP/2009 09‐05‐2016 HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF 272993 DIABETES AND METABOLIC DISORDERS 2707/DELNP/2007 11‐05‐2016 "COMBINATIONS OF NICOTINIC ACETYLCHOLINE ALPHA 7 273041 RECEPTOR AGONISTS" 1919/CHENP/2008 12‐05‐2016 PHYSICALLY AND CHEMICALLY STABLE, WATER‐SOLUBLE, 273059 AMPHIPHILIC POLYMER‐PDGF COMPLEX AND A METHOD THEREOF 4187/KOLNP/2008 16‐05‐2016 ANTIFUNGAL AGENTS 273093 7490/DELNP/2006 18‐05‐2016 "PHARMACEUTICAL COMPOSITIONS FOR DRUG DELIVERY" 273120 1702/MUM/2009 19‐05‐2016 WATER‐BASED ANTI‐LICE PHARMACEUTICAL COMPOSITIONS AND 273136 THE PROCESS FOR PREPARING THE SAME 1945/MUMNP/2007 23‐05‐2016 A COMPOSITION FREE FROM PRESERVING AGENT AND PARTICLES 273167 2067/KOLNP/2008 24‐05‐2016 AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS 273186 741/MUMNP/2008 25‐05‐2016 A COMPOSITION THAT COMPRISES DISACCHARIDE 273212 573/DELNP/2009 26/05/2016 "N‐TERMINAL DERIVATISATION OF PROTEINS WITH 273231 POLYSACCHARIDES" 2318/DELNP/2009 27‐05‐2016 "AN IpaD POLYPEPTIDE AND KIT THEREOF" 273263 4515/DELNP/2009 30/05/2016 POLYPEPTIDE FILMS AND METHODS 273297 7300/DELNP/2007 31‐05‐2016 "VACCINE" 273328 369/CHE/2010 31‐05‐2016 A THIN FILM DRUG DELIVERY SYSTEM AND A PROCESS FOR MAKING 273337 THE SAME 2501/DELNP/2010 31‐05‐2016 "HYDROXYAPATITE‐TARGETING MULTIARM POLYMERS AND 273340 CONJUGATES MADE THEREFROM" 1170/MUMNP/2010 03‐06‐2016 PERSONAL CARE COMPOSITION 273405 1707/KOLNP/2008 07‐06‐2016 METHOD FOR PREPARING A FAXTOR IX FORMULATION 273436 4563/DELNP/2009 08‐06‐2016 "A linear cyclodextrin containing polymer conjugate " 273456 2025/MUMNP/2010 09‐06‐2016 PROCESS FOR THE PREPARATION OF DONEPEZIL HYDROCHLORIDE 273476 477/MUMNP/2009 09‐06‐2016 COMPOSITION FOR PROMOTING ACTIVITY OF ANTI‐CANCER 273477 THERAPIES 2051/MUMNP/2008 12‐06‐2016 SKIN LIGHTENING AGENTS, COMPOSITIONS AND METHODS 277929 37/MUMNP/2010 14‐06‐2016 PIPERIDINE/PIPERAZINE DERIVATIVES 273531 5131/DELNP/2009 15‐06‐2016 "PHARMACEUTICAL COMPOSITION FOR TREATING INFLUENZA 273554 VIRUS INFECTION" 1994/CHE/2006 15‐06‐2016 AN IMPROVED PROCESS FOR PREPARING ROSUVASTATIN CALCIUM 273564 2266/DEL/2009 16‐06‐2016 "USE OF IVABRADINE AS DIAGNOSTIC AGENT IN THE METHOD OF 273579 CORONARY ANGIOGRAPHY BY MULTISLICE COMPUTED TOMOGRAPHY" 7760/DELNP/2009 17‐06‐2016 "Valproate, dicloroacetate and alkyl phosphate esters of honokiol 273597 and their use in the treating cancers" 690/MUM/2008 20‐06‐2016 FORMULTION CONTAINING ANTIARRHYTHMIC DRUG 273623 1780/KOLNP/2009 21‐06‐2016 DICLOFENAC GEL 273641 692/MUM/2008 21‐06‐2016 ENTERIC COATED COMPOSITION OF PANTOPRAZOLE 273642 Page 2 of 85 2714/MUMNP/2008 21‐06‐2016 A BIOADHESIVE CONTROLLED RELEASE MONOLITHIC TABLET FOR 273646 THE TREATMENT OF FEMALE GENITAL DISORDERS 68/DELNP/2008 22‐06‐2016 PROCESS FOR SYNTHESIZING A CETP INHIBITOR. 273675 1008/CHE/2005 24‐06‐2016 NEW IMPROVED GEL FORMULATION 273717 3327/CHENP/2008 24‐06‐2016 RECOMBINANT MONOVALENT ANTIBODIES AND METHODS FOR 273720 PRODUCTION THEREOF 1327/MUM/2005 27‐06‐2016 IMPROVED COMPOSITIONS FOR CANCER THERAPY 273763 3052/DELNP/2008 28‐06‐2016 "INTERLEUKIN‐13 ANTIBODY COMPOSITION" 273776 10732/DELNP/2008 29‐06‐2016 FIBER‐REINFORCED COMPOSITES AND METHOD FOR THE 273818 MANUFACTURE THEREOF 8968/DELNP/2007 29‐06‐2016 "LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL" 273815 1074/KOL/2008 30‐06‐2016 A METHOD FOR PREPARING A PHARMACEUTICAL COMPOSITION 273880 FOR TREATMENT OF PSORIASIS 4529/DELNP/2007 30‐06‐2016 "A METHOD FOR STABILIZING DONEPEZIL OR A PHARMACEUTICAL 273889 SALT THEREOF" 4148/CHENP/2008 01‐07‐2016 COMPOSITION, PROCESS FOR PREPARATION AND METHOD OF USE 273958 1810/DELNP/2008 04‐07‐2016 "An aqueous, stable, sterile argatroban composition" 273991 3739/CHENP/2009 10‐07‐2016 “AN HBV VACCINE AND A PROCESS OF PREPARING THE SAME” 276267 911/CHENP/2008 11‐07‐2016 PHOSPHONATED RIFAMYCINS 274081 4652/DELNP/2007 11‐07‐2016 'COMPOSITIONS COMPRISING ORNITHINE AND PHENYLACETATE OR 274090 PHENYLBUTYRATE FOR TREATING HEPATIC ENCEPHALOPATHY' 481/MUM/2010 11‐07‐2016 "AN IMPROVED PROCESS FOR THE PREPARATION OF HMG‐COA 274096 REDUCTASE INHIBITORS VIA CHIRAL DIOL SULFONES INTERMEDIATES" 265/KOLNP/2010 12‐07‐2016 PROCESS FOR THE PREPARATION OF CONTROLLED‐RELEASE SOLID 274107 FORMULATIONS CONTAINING OXCARBAZEPINE, AND FORMULATIONS OBTAINABLE BY SAID PROCESS 429/MUMNP/2010 12‐07‐2016 POLYPEPTIDE, MATRIX AND METHOD OF INDUCING EX VIVO TISSUE 274118 FORMATION 718/MUMNP/2010 12‐07‐2016 COMPLEX COMPRISING SOLUBLE FRAGMENT OF INFLUENZA VIRUS 274124 PB2 PROTEIN CAPABLE OF BINDING RNA‐CAP 3420/DELNP/2008 13‐07‐2016 METHOD OF INHIBITING THE PROLIFERATION AND MIGRATION OF 274146 HELICOBACTER PYLORI 1196/DEL/2010 14‐07‐2016 SALBUTAMOL PATCH AND A PROCESS OF PREPARATION THEREOF 274160 7665/DELNP/2009 14‐07‐2016 "BENEFIT AGENT CONTAINING DELIVERY PARTICLE" 274161 6760/DELNP/2007 14‐07‐2016 "PHARMACEUTICAL FORMS WITH IMPROVED PHARMACOKINETIC 274179 PROPERTIES" 4366/CHENP/2008 14‐07‐2016 PHARMACEUTICAL COMPOSITION AND A SOFT GELATIN CAPSULE 274184 FORMULATION COMPRISING A BI‐CYCLIC COMPOUND 1902/DELNP/2008 15‐07‐2016 "POLYSACCHARIDE VACCINE FOR STAPHYLOCOCCAL INFECTIONS" 274200 1295/KOLNP/2009 15‐07‐2016 METHODS OF SYNTHESIZING PHARMACEUTICAL SALTS OF A 274223 FACTOR XA INHIBITOR 1951/DELNP/2009 15‐07‐2016 "VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT" 274225 5462/DELNP/2007 15‐07‐2016 "ANTITUMOR AGENT" 274234 1610/MUMNP/2009 19‐07‐2016 A PROCESS OF PREPARING CRYSTALLINE POLYMORPHIC FORMS OF 274275 COUMPOUND I 140/MUM/2009 21‐07‐2016 CONTROLLED RELEASE CHRONOTHERAPEUTIC PHARMACEUTICAL 274321 COMPOSITION 255/CHE/2006

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    85 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us